Infectious Diseases (except HIV/AIDS)
-
Sputnik Light booster after Sputnik V vaccination induces robust neutralizing antibody response to B.1.1.529 (Omicron) SARS-CoV-2 variant
This article has 20 authors:Reviewed by ScreenIT
-
Analytical Sensitivity of Eight Different SARS-CoV-2 Antigen-Detecting Rapid Tests for Omicron-BA.1 Variant
This article has 13 authors:Reviewed by Rapid Reviews Infectious Diseases, ScreenIT
-
Breakthrough SARS-CoV-2 infections during periods of delta and omicron predominance, South Africa
This article has 13 authors:Reviewed by ScreenIT
-
Therapies for Long COVID in non-hospitalised individuals: from symptoms, patient-reported outcomes and immunology to targeted therapies (The TLC Study)
This article has 43 authors:Reviewed by ScreenIT
-
Evaluation of the Roche SARS-CoV-2 Rapid Antibody Test in Samples from Vaccinated Individuals
This article has 2 authors:Reviewed by ScreenIT
-
Activity of convalescent and vaccine serum against a B.1.1.529 variant SARS-CoV-2 isolate
This article has 18 authors:Reviewed by ScreenIT
-
Real-world clinical outcomes of treatment with casirivimab-imdevimab among patients with mild-to-moderate coronavirus disease 2019 during the Delta variant pandemic
This article has 49 authors:Reviewed by ScreenIT
-
Binding and neutralizing antibody responses to SARS-CoV-2 in very young children exceed those in adults
This article has 9 authors:Reviewed by ScreenIT
-
Outpatient Therapies for COVID-19: How Do We Choose?
This article has 5 authors:Reviewed by ScreenIT
-
Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study
This article has 28 authors:Reviewed by ScreenIT